Showing results (491-500 of 557) with videos related to
Sort By:
Pageof 56
Neurosurgery|January 14, 2026
Stereotactic Radiosurgery for Primary Central Nervous System Lymphoma: Results From the International Radiosurgery Research FoundationTrent Kite, Rodney E Wegner, Steven Karlovits, et al.Neurosurgery|August 15, 2023
Intratumoral Hemorrhage in Vestibular Schwannomas After Stereotactic Radiosurgery: Multi-Institutional StudyOthman Bin-Alamer, Hussam Abou-Al-Shaar, Arka N Mallela, et al.Journal of Neuro-Oncology|July 31, 2026
Personalized prediction of local control after stereotactic radiosurgery for craniopharyngioma: a multicenter machine learning survival modelJheremy S Reyes, Constantinos G Hadjipanayis, Kenneth Bernstein, et al.Cancers|March 10, 2022
Comparison of Active Surveillance to Stereotactic Radiosurgery for the Management of Patients with an Incidental Frontobasal Meningioma-A Sub-Analysis of the IMPASSE StudyAbdurrahman I Islim, Georgios Mantziaris, Stylianos Pikis, et al.Journal of Neuro-Oncology|August 3, 2026
Stereotactic radiosurgery offers long-term tumor control for craniopharyngioma: a multi-institutional analysis of clinical and imaging outcomes from the International Radiosurgery Research Foundation (IRRF)Ajay Niranjan, Jheremy S Reyes, Constantinos G Hadjipanayis, et al.Neurosurgery|November 6, 2024
Vestibular Schwannoma Koos Grade II International Study of Active Surveillance Versus Stereotactic Radiosurgery: The VISAS-K2 StudyOthman Bin-Alamer, Hussam Abou-Al-Shaar, Selcuk Peker, et al.International Journal of Radiation Oncology, Biology, Physics|April 8, 2024
Vestibular Schwannoma International Study of Active Surveillance Versus Stereotactic Radiosurgery: The VISAS StudyOthman Bin-Alamer, Hussam Abou-Al-Shaar, Selcuk Peker, et al.Cancer|January 25, 2022
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter studyEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.Pageof 56